Safety and effectiveness of 4-week therapy with aceclofenac controlled release once a day

Aceclofenac controlled-release (CR) is a once-a-day tablet with 200 mg of aceclofenac, and is bioequivalent to conventional aceclofenac. However, its safety in humans has not been well studied in Korea. Therefore, we aimed to evaluate the overall incidence and patterns of adverse events (AEs), the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ju-cheol, Chung, Yoon Hee, Park, Taejun, Park, Seung Yeon, Jung, Tae Woo, Abd El-Aty, A. M., Bang, Joon Seok, Jeong, Ji Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530112/
https://www.ncbi.nlm.nih.gov/pubmed/36192565
http://dx.doi.org/10.1038/s41598-022-20633-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530112/
https://www.ncbi.nlm.nih.gov/pubmed/36192565
http://dx.doi.org/10.1038/s41598-022-20633-6

Ejemplares similares